Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for CGEM

Stock NameCullinan Oncology LLC
TickerCGEM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025
(RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc
Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.
American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CGEM holdings

DateNumber of CGEM Shares HeldBase Market Value of CGEM SharesLocal Market Value of CGEM SharesChange in CGEM Shares HeldChange in CGEM Base ValueCurrent Price per CGEM Share HeldPrevious Price per CGEM Share Held
2025-11-12 (Wednesday)17,289CGEM holding decreased by -56USD 144,363CGEM holding increased by 9072USD 144,363-56USD 9,072 USD 8.34999 USD 7.8
2025-11-11 (Tuesday)17,345USD 135,291CGEM holding increased by 6244USD 135,2910USD 6,244 USD 7.8 USD 7.44001
2025-11-10 (Monday)17,345USD 129,047CGEM holding increased by 4336USD 129,0470USD 4,336 USD 7.44001 USD 7.19003
2025-11-07 (Friday)17,345USD 124,711CGEM holding decreased by -2775USD 124,7110USD -2,775 USD 7.19003 USD 7.35001
2025-11-06 (Thursday)17,345CGEM holding decreased by -56USD 127,486CGEM holding increased by 285USD 127,486-56USD 285 USD 7.35001 USD 7.30998
2025-11-05 (Wednesday)17,401CGEM holding decreased by -560USD 127,201CGEM holding decreased by -5710USD 127,201-560USD -5,710 USD 7.30998 USD 7.39998
2025-11-04 (Tuesday)17,961CGEM holding decreased by -112USD 132,911CGEM holding decreased by -8239USD 132,911-112USD -8,239 USD 7.39998 USD 7.80999
2025-11-03 (Monday)18,073CGEM holding decreased by -112USD 141,150CGEM holding decreased by -16332USD 141,150-112USD -16,332 USD 7.80999 USD 8.65999
2025-10-31 (Friday)18,185USD 157,482CGEM holding increased by 20003USD 157,4820USD 20,003 USD 8.65999 USD 7.56002
2025-10-30 (Thursday)18,185USD 137,479CGEM holding decreased by -2364USD 137,4790USD -2,364 USD 7.56002 USD 7.69002
2025-10-29 (Wednesday)18,185USD 139,843CGEM holding decreased by -14548USD 139,8430USD -14,548 USD 7.69002 USD 8.49002
2025-10-28 (Tuesday)18,185CGEM holding increased by 168USD 154,391CGEM holding increased by 9174USD 154,391168USD 9,174 USD 8.49002 USD 8.06
2025-10-27 (Monday)18,017USD 145,217CGEM holding increased by 5405USD 145,2170USD 5,405 USD 8.06 USD 7.76
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00B3VWM098

Show aggregate share trades of CGEM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-568.4907.720 7.797USD -437 9.31 Profit of 85 on sale
2025-11-06SELL-567.8207.060 7.136USD -400 9.35 Profit of 124 on sale
2025-11-05SELL-5607.5207.170 7.205USD -4,035 9.36 Profit of 1,209 on sale
2025-11-04SELL-1127.8007.360 7.404USD -829 9.37 Profit of 221 on sale
2025-11-03SELL-1128.7707.760 7.861USD -880 9.38 Profit of 170 on sale
2025-10-28BUY1688.4908.550 8.544USD 1,435 9.41
2025-10-24SELL-567.7608.160 8.120USD -455 9.43 Profit of 73 on sale
2025-10-15BUY3368.6308.650 8.648USD 2,906 9.47
2025-10-02BUY565.7506.050 6.020USD 337 9.51
2025-09-30BUY1125.9306.055 6.042USD 677 9.55
2025-08-21SELL-567.6707.750 7.742USD -434 9.65 Profit of 107 on sale
2025-07-31BUY1687.7708.150 8.112USD 1,363 9.68
2025-06-30SELL-1127.5308.000 7.953USD -891 9.92 Profit of 220 on sale
2025-06-25SELL-567.9208.000 7.992USD -448 9.96 Profit of 110 on sale
2025-06-20SELL-1127.6708.180 8.129USD -910 10.01 Profit of 211 on sale
2025-05-23BUY567.8107.860 7.855USD 440 10.26
2025-05-19SELL-567.7107.770 7.764USD -435 10.34 Profit of 144 on sale
2025-05-15SELL-1687.2407.750 7.699USD -1,293 10.39 Profit of 453 on sale
2025-05-12SELL-567.9108.130 8.108USD -454 10.47 Profit of 132 on sale
2025-05-09SELL-567.5408.005 7.959USD -446 10.50 Profit of 142 on sale
2025-04-30SELL-568.2808.405 8.392USD -470 10.65 Profit of 127 on sale
2025-04-24SELL-1128.1408.411 8.384USD -939 10.76 Profit of 266 on sale
2025-04-17SELL-567.8907.989 7.979USD -447 10.90 Profit of 164 on sale
2025-04-15SELL-1687.8008.095 8.066USD -1,355 10.97 Profit of 488 on sale
2025-04-14SELL-1687.7407.970 7.947USD -1,335 11.01 Profit of 514 on sale
2025-04-09SELL-2247.7908.100 8.069USD -1,807 11.12 Profit of 683 on sale
2025-04-07SELL-3927.2507.390 7.376USD -2,891 11.21 Profit of 1,503 on sale
2025-04-04SELL-5607.4107.615 7.594USD -4,253 11.25 Profit of 2,049 on sale
2025-03-31BUY567.5707.900 7.867USD 441 11.39
2025-03-19SELL-1128.6508.920 8.893USD -996 11.71 Profit of 316 on sale
2025-03-14SELL-3368.7909.010 8.988USD -3,020 11.83 Profit of 954 on sale
2025-03-13SELL-1148.9209.380 9.334USD -1,064 11.87 Profit of 289 on sale
2025-03-12SELL-1,9389.0809.190 9.179USD -17,789 11.91 Profit of 5,294 on sale
2025-03-07SELL-1148.7109.090 9.052USD -1,032 12.06 Profit of 343 on sale
2025-03-06SELL-1718.5108.620 8.609USD -1,472 12.12 Profit of 600 on sale
2025-03-03SELL-578.0008.635 8.572USD -489 12.31 Profit of 213 on sale
2025-02-28SELL-41,0418.4908.680 8.661USD -355,456 12.37 Profit of 152,329 on sale
2025-02-26SELL-1648.4508.705 8.679USD -1,423 12.50 Profit of 627 on sale
2025-02-25SELL-4928.5608.830 8.803USD -4,331 12.57 Profit of 1,854 on sale
2025-02-18BUY8209.2609.825 9.768USD 8,010 12.90
2025-02-13BUY1649.5909.960 9.923USD 1,627 13.10
2025-02-12BUY1649.8909.950 9.944USD 1,631 13.16
2025-02-11BUY4929.81010.270 10.224USD 5,030 13.23
2025-02-06BUY1,47610.35010.700 10.665USD 15,742 13.43
2025-01-27BUY16410.30010.880 10.822USD 1,775 14.07
2024-12-30BUY82012.20012.280 12.272USD 10,063 14.39
2024-12-06BUY65613.06013.210 13.195USD 8,656 14.55
2024-12-05BUY16412.44012.990 12.935USD 2,121 14.62
2024-12-04BUY82012.96013.025 13.018USD 10,675 14.68
2024-11-29BUY82013.45013.570 13.558USD 11,118 14.86
2024-11-27BUY65613.09013.110 13.108USD 8,599 15.02
2024-11-26BUY16412.77013.200 13.157USD 2,158 15.12
2024-11-21BUY82012.22012.840 12.778USD 10,478 15.54
2024-11-20BUY49212.58013.515 13.422USD 6,603 15.71
2024-11-18BUY1,96313.45014.145 14.076USD 27,630 16.01
2024-11-12BUY1,30416.02017.503 17.355USD 22,631 16.01
2024-11-08BUY81516.02016.450 16.407USD 13,372 16.01
2024-11-07BUY2,44515.58017.190 17.029USD 41,636 16.04
2024-11-06BUY32616.48017.000 16.948USD 5,525 16.01
2024-10-31BUY16315.55016.210 16.144USD 2,631 16.11
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1991,7130453,13720.2%
2025-09-1829,90964374,3228.0%
2025-09-1729,113561152,08119.1%
2025-09-1641,7652156,36626.7%
2025-09-1569,037556213,45032.3%
2025-09-1276,0840383,50219.8%
2025-09-1166,615867581,52011.5%
2025-09-1055,0970308,72517.8%
2025-09-09106,4910278,73338.2%
2025-09-0844,9790172,18226.1%
2025-09-0592,5842,960314,97529.4%
2025-09-04218,97713,252745,97129.4%
2025-09-0359,5350162,54436.6%
2025-09-0230,2150107,25628.2%
2025-08-2928,9550102,69028.2%
2025-08-2839,008089,89543.4%
2025-08-2750,5440153,48132.9%
2025-08-2638,6843378,65710.2%
2025-08-2517,620058,53130.1%
2025-08-2273,1000173,43542.1%
2025-08-2127,559085,31232.3%
2025-08-2037,739091,41841.3%
2025-08-1937,960083,52645.4%
2025-08-1877,2120180,13542.9%
2025-08-1537,9960114,06733.3%
2025-08-1415,1790186,7068.1%
2025-08-1325,9030130,51119.8%
2025-08-1244,9730119,05337.8%
2025-08-1141,962128103,18340.7%
2025-08-0867,3042,573153,71443.8%
2025-08-0780,102176173,93646.1%
2025-08-0621,373051,51641.5%
2025-08-0522,741058,65038.8%
2025-08-0426,114093,27628.0%
2025-08-0138,24057976,87449.7%
2025-07-3135,0275868,86450.9%
2025-07-3080,5000739,89910.9%
2025-07-2958,3939130,45944.8%
2025-07-2827,557046,54859.2%
2025-07-2521,73617636,20960.0%
2025-07-2454,73018130,09542.1%
2025-07-2377,9670133,95558.2%
2025-07-2249,802089,67155.5%
2025-07-2127,480040,11268.5%
2025-07-1829,606050,25158.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.